Impact of hepatitis C virus infection on lifestyle

World Journal of Gastroenterology

Volumn 13, Issue 19, 2007, Pages 2722-2726

  Scognamiglio, Paola ^a   Galati, Vincenzo ^a   Navarra, Assunta ^a   Longo, Maria Antonella ^a   Aloisi, Maria Stella ^a   Antonini, Maria Giulia ^b   Puoti, Massimo ^b   Almasio, Piero Luiqi ^c   Ippolito, Giuseppe ^a   Girardi, Enrico ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Alcohol consumption; Diet; Hepatitis C virus; Lifestyle habits; Physical activity; Smoking

Indexed keywords

ADULT; AGED; ALCOHOL ABSTINENCE; ARTICLE; DIET RESTRICTION; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT COUNSELING; PHYSICAL ACTIVITY; PHYSICIAN; QUESTIONNAIRE; SMOKING CESSATION; SMOKING HABIT; SPORT;

EID: 34250738796     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i19.2722     Document Type: Article

References (30)

1. Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999; 31 Suppl 1: 17-24
2. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005; 41: 790-800
3. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 2002; 36: S3-S20
4. National Institute for Clinical Excellence (2000). Guidance on the use of ribavirin and interferon alpha for hepatitis C, NICE Technology Appraisal No. 14. London: National Institute for Clinical Excellence. Available from URL: http//www.nice.org.uk; www.nice.org.uk/TA075guidance
5. British Columbia Medical Association; Ministry of Health Services; Ministry of Health Planning. Guidelines and Protocols Advisory Committee. British Columbia Centre for Disease Control. Clinical Management of Chronic Hepatitis C. Available from URL: http//www.bccdc.org/hepatitis/research
6. Canadian association for study of the liver. The management of viral hepatitis. Consensus Conference Montreal, Quebec March 1999. Available from URL: http//www.lhsc.on.ca/casl/cont.htm
7. Booth JC, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut 2001; 49 Suppl 1: I1-I21
8. Agence Nationale d'Accréditation et d'Évaluation en Santé. Consensus Conference. Treatment of hepatitis C. Paris, France, 27-28 February 2002. Available from URL: http//www.anaes.fr
9. Kubo N, Furusyo N, Nakashima H, Kashiwagi K, Hayashi J. Strenuous physical labor is important as a cause of elevated alanine aminotransferase levels in Japanese patients with chronic hepatitis C viremia. Eur J Epidemiol 2005; 20: 251-261
10. El-Zayadi A, Selim O, Hamdy H, El-Tawil A, Badran HM, Attia M, Saeed A. Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients. World J Gastroenterol 2004; 10: 2963-2966
11. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, Rueff B, Valla DC, Degos F. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001; 34: 121-125
12. Sladden TJ, Hickey AR, Dunn TM, Beard JR. Hepatitis C virus infection: impacts on behaviour and lifestyle. Aust N Z J Public Health 1998; 22: 509-511
13. Castera L, Constant A, Bernard PH, de Ledinghen V, Couzigou P. Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C. J Viral Hepat 2006; 13: 482-488
14. Fabris P, Tositti G, Giordani MT, Baldo V, Grasso A, Pignattari E, Canton S, Rossato S, Floreani A. Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle. Aliment Pharmacol Ther 2006; 23: 1161-1170
15. Jessor R. Prevention of alcohol problems. In: Problems Related to Alcohol Consumption: Report of a WHO Expert Committee. Technical Report Series No. 650. Geneva: World Health Organization, 1980: 28-44
16. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832
17. Hezode C, Lonjon I, Roudot-Thoraval F, Pawlotsky JM, Zafrani ES, Dhumeaux D. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther 2003; 17: 1031-1037
18. Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, Degott C, Valla D, Erlinger S, Rueff B. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998; 27: 1717-1722
19. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, Naramoto J. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000; 151: 131-139
20. Mukaiya M, Nishi M, Miyake H, Hirata K. Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 1998; 45: 2328-2332
21. Yu MW, Chiu YH, Yang SY, Santella RM, Chern HD, Liaw YF, Chen CJ. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 1999; 80: 598-603
22. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 811-815
23. Gallus S, Pacifici R, Colombo P, La Vecchia C, Garattini S, Apolone G, Zuccaro P. Tobacco dependence in the general population in Italy. Ann Oncol 2005; 16: 703-706
24. Harrington DW. Viral hepatitis and exercise. Med Sci Sports Exerc 2000; 32: S422-S430
25. Ritland S, Foss NE, Gjone E. Physical activity in liver disease and liver function in sportsmen. Scand J Soc Med Suppl 1982; 29: 221-226
26. Ritland S, Foss NE, Skrede S. The effect of a standardized work load on 'liver tests' in patients with chronic active hepatitis. Scand J Gastroenterol 1982; 17: 1013-1016
27. Herrine SK. Approach to the patient with chronic hepatitis C virus infection. Ann Intern Med 2002; 136: 747-757
28. Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53: 413-419
29. Wendland BE. Nutritional guidelines for persons infected with the hepatitis C virus: a review of the literature. Can J Diet Pract Res 2001; 62: 7-15
30. Corrao G, Ferrari PA, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol 1995; 142: 1136-1146